Skip to content

Author

Lampros Chrysavgis

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

From Single Agents to Synergy: Redefining Therapeutic Strategies in MASLD

The recent approvals of resmetirom and semaglutide have marked a pivotal advance in the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Nevertheless, the modest fibrosis responses observed with current monotherapies and the persistence of substantial residual disease burden highlight the...

Lampros Chrysavgis, E. Cholongitas · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.